awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26747768-32590FB2-EA92-4532-8C7B-5570B799B103
Q26747768-32590FB2-EA92-4532-8C7B-5570B799B103
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747768-32590FB2-EA92-4532-8C7B-5570B799B103
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
P2860
Q26747768-32590FB2-EA92-4532-8C7B-5570B799B103
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747768-32590FB2-EA92-4532-8C7B-5570B799B103
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a5468a9612d40e0d601c8934a71bbd600760eb6
P2860
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells